Novartis
NVS
#50
Rank
$232.55 B
Marketcap
$113.77
Share price
-0.61%
Change (1 day)
14.39%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

P/S ratio for Novartis (NVS)

P/S ratio as of October 2024 (TTM): 4.76

According to Novartis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.7596. At the end of 2024 the company had a P/S ratio of 4.45.

P/S ratio history for Novartis from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.45-0.05%
20234.4513.44%
20223.925.53%
20213.72-14.86%
20204.36-1.11%
20194.417.08%
20184.124.79%
20173.9312.4%
20163.50-15.42%
20154.14-0.95%
20144.1819.64%
20133.4931.91%
20122.6513.79%
20112.33-10.9%
20102.61-5.84%
20092.774.75%
20082.65-16.59%
20073.17-17.67%
20063.852.02%
20053.78-13%
20044.34-4.67%
20034.5516.84%
20023.90-18.42%
20014.78

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.47-6.08%๐Ÿ‡บ๐Ÿ‡ธ USA
2.89-39.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.46-6.24%๐Ÿ‡บ๐Ÿ‡ธ USA
2.77-41.77%๐Ÿ‡ซ๐Ÿ‡ท France
2.10-55.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.22-74.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
2.36-50.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.79 0.74%๐Ÿ‡บ๐Ÿ‡ธ USA
4.98 4.63%๐Ÿ‡ฌ๐Ÿ‡ง UK